RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Skull Neoplasms
Accession: DOID:9001331
browse the term
Definition: Neoplasms of the bony part of the skull.
Synonyms: exact_synonym: Skull Neoplasm
primary_id: MESH:D012888
G
DHFR
dihydrofolate reductase
IAGP
ClinVar Annotator: match by term: Cavernous sinus meningioma
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:31371350 PMID:31627758
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
KMT2D
lysine methyltransferase 2D
IAGP
ClinVar Annotator: match by term: Cavernous sinus meningioma
ClinVar
PMID:21671394 PMID:22126750 PMID:28492532
NCBI chr12:49,018,978...49,060,794
Ensembl chr12:49,018,975...49,060,794
G
MSH3
mutS homolog 3
IAGP
ClinVar Annotator: match by term: Cavernous sinus meningioma
ClinVar
PMID:25741868 PMID:26467025 PMID:28492532 PMID:31371350 PMID:31627758
NCBI chr 5:80,654,652...80,876,815
Ensembl chr 5:80,654,652...80,876,815
G
CDC73
cell division cycle 73
IAGP
ClinVar Annotator: match by term: Cystic parathyroid adenoma
ClinVar
PMID:12434154
NCBI chr 1:193,122,031...193,254,815
Ensembl chr 1:193,121,983...193,254,815
G
B3GALT2
beta-1,3-galactosyltransferase 2
IAGP
ClinVar Annotator: match by term: Hyperparathyroidism 2 with jaw tumors
ClinVar
PMID:25637381
NCBI chr 1:193,178,730...193,186,613
Ensembl chr 1:193,178,730...193,186,613
G
CDC73
cell division cycle 73
IAGP EXP
ClinVar Annotator: match by term: Hyperparathyroidism 2 with jaw tumors ClinVar Annotator: match by term: Hyperparathyroidism 2 | ClinVar Annotator: match by term: Hyperparathyroidism 2 with jaw tumors CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:12434154 PMID:12960210 PMID:14585940 PMID:14715834 PMID:15070940 PMID:15613436 PMID:17065424 PMID:20052758 PMID:20301744 PMID:21652691 PMID:25637381 PMID:25741868 PMID:28492532 PMID:29641532 More...
NCBI chr 1:193,122,031...193,254,815
Ensembl chr 1:193,121,983...193,254,815
G
APC
APC regulator of WNT signaling pathway
ISO
RGD
PMID:17360473
RGD:1601201
NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239
G
BRAF
B-Raf proto-oncogene, serine/threonine kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859340
NCBI chr 7:140,713,328...140,924,929
Ensembl chr 7:140,719,327...140,924,929
G
CTNNB1
catenin beta 1
ISO
mRNA:increased expression:small intestine
RGD
PMID:17259108
RGD:1599632
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
DEFB1
defensin beta 1
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:11934727
RGD:4892265
NCBI chr 8:6,870,592...6,877,936
Ensembl chr 8:6,870,592...6,877,936
G
DEFB4A
defensin beta 4A
IEP
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:11934727
RGD:4892265
NCBI chr 8:7,894,677...7,896,716
Ensembl chr 8:7,894,677...7,896,716 Ensembl chr 8:7,894,677...7,896,716
G
SMO
smoothened, frizzled class receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859340
NCBI chr 7:129,188,633...129,213,545
Ensembl chr 7:129,188,633...129,213,545
G
CDKN1A
cyclin dependent kinase inhibitor 1A
IEP
RGD
PMID:15040115
RGD:8662355
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CLU
clusterin
IEP
RGD
PMID:19903339
RGD:9014708
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
SOX2
SRY-box transcription factor 2
IAGP
DNA:amplification
RGD
PMID:23544055
RGD:8661654
NCBI chr 3:181,711,925...181,714,436
Ensembl chr 3:181,711,925...181,714,436
G
TP53
tumor protein p53
IAGP
RGD
PMID:19950227
RGD:8547762
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
ABCB1
ATP binding cassette subfamily B member 1
severity
IEP
Nasal Type;protein:increased expression:nasal cavity (human)
RGD
PMID:18756548
RGD:8657087
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
CD274
CD274 molecule
disease_progression
IEP
associated with Epstein-Barr Virus Infections
RGD
PMID:27595782
RGD:41412182
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
CFLAR
CASP8 and FADD like apoptosis regulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15924153
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
FAS
Fas cell surface death receptor
IAGP
DNA:insertion, deletions:cds:multiple (human)
RGD
PMID:12466128
RGD:8662407
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
GPX3
glutathione peroxidase 3
treatment
IEP
associated with ethmoid sinus cancer and Neoplasm Metastasis
RGD
PMID:29496492
RGD:151708712
NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
G
JAK3
Janus kinase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22705984 PMID:23689514
NCBI chr19:17,824,782...17,847,982
Ensembl chr19:17,824,780...17,848,071
G
PRDM1
PR/SET domain 1
disease_progression
IEP
RGD
PMID:24438193
RGD:150530467
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
STAT3
signal transducer and activator of transcription 3
IEP
protein:increased expression:nasal cavity (human)
RGD
PMID:17225522
RGD:153298933
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STAT5B
signal transducer and activator of transcription 5B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29200404
NCBI chr17:42,199,177...42,288,370
Ensembl chr17:42,199,176...42,288,633
G
DMBT1
deleted in malignant brain tumors 1
ISO
mRNA, Protein:increased expression
RGD
PMID:12419858
RGD:1599782
NCBI chr10:122,560,754...122,643,736
Ensembl chr10:122,560,665...122,643,736
G
MMP2
matrix metallopeptidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16178123
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
ANXA1
annexin A1
IEP
RGD
PMID:20970165
RGD:7421559
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
G
ANXA2
annexin A2
disease_progression
IEP
RGD
PMID:20970165
RGD:7421559
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
G
TP53
tumor protein p53
treatment
IAGP
DNA:mutations:cds:
RGD
PMID:22575263 PMID:23369851
RGD:8547763 , RGD:8547764
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
MAML3
mastermind like transcriptional coactivator 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859338
NCBI chr 4:139,716,753...140,154,184
Ensembl chr 4:139,716,753...140,154,184
G
PAX3
paired box 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859338
NCBI chr 2:222,199,887...222,298,998
Ensembl chr 2:222,199,887...222,298,998
G
SMARCB1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
IEP
RGD
PMID:30120966
RGD:127285653
NCBI chr22:23,786,966...23,838,009
Ensembl chr22:23,786,931...23,838,009
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all